These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 39200363)

  • 1. Dendrimers-Novel Therapeutic Approaches for Alzheimer's Disease.
    Mroziak M; Kozłowski G; Kołodziejczyk W; Pszczołowska M; Walczak K; Beszłej JA; Leszek J
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease.
    Moreira DA; Santos SD; Leiro V; Pêgo AP
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation.
    Wasiak T; Ionov M; Nieznanski K; Nieznanska H; Klementieva O; Granell M; Cladera J; Majoral JP; Caminade AM; Klajnert B
    Mol Pharm; 2012 Mar; 9(3):458-69. PubMed ID: 22206488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro.
    Szwed A; Miłowska K; Michlewska S; Moreno S; Shcharbin D; Gomez-Ramirez R; de la Mata FJ; Majoral JP; Bryszewska M; Gabryelak T
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32182909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimers: Patents for Alzheimer's Disease.
    Maheshwari S; Singh A
    Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
    Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
    Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Copper in Tau-Related Pathology in Alzheimer's Disease.
    Zubčić K; Hof PR; Šimić G; Jazvinšćak Jembrek M
    Front Mol Neurosci; 2020; 13():572308. PubMed ID: 33071757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.
    Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I
    Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
    Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
    PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer's Disease.
    Olesen MA; Quintanilla RA
    Mol Neurobiol; 2023 Oct; 60(10):5691-5707. PubMed ID: 37332018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    Rüb U; Stratmann K; Heinsen H; Seidel K; Bouzrou M; Korf HW
    J Alzheimers Dis; 2017; 57(3):683-696. PubMed ID: 28269779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau aggregation is a therapeutic target for Alzheimer's disease.
    Takashima A
    Curr Alzheimer Res; 2010 Dec; 7(8):665-9. PubMed ID: 20678070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease - Future Therapy Based on Dendrimers.
    Aliev G; Ashraf GM; Tarasov VV; Chubarev VN; Leszek J; Gasiorowski K; Makhmutovа A; Baeesa SS; Avila-Rodriguez M; Ustyugov AA; Bachurin SO
    Curr Neuropharmacol; 2019; 17(3):288-294. PubMed ID: 30227819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease.
    Arora S; Sharma D; Layek B; Singh J
    Mol Pharm; 2021 Dec; 18(12):4237-4255. PubMed ID: 34705472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.
    Brunden KR; Ballatore C; Crowe A; Smith AB; Lee VM; Trojanowski JQ
    Exp Neurol; 2010 Jun; 223(2):304-10. PubMed ID: 19744482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Gholami A
    Neurosci Lett; 2023 Nov; 817():137532. PubMed ID: 37866702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.